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introduction: The aim of this review is to provide an overview of the evidence for the use 
of biologic mesh in the reconstruction of the pelvic floor after extralevator abdominoper-
ineal excision of the rectum (ELAPE).
Methods: A systematic search of PubMed was conducted using the search terms: 
“ELAPE,” “extralevator abdominoperineal excision of rectum,” or “extralevator abdomi-
noperineal resection.” The search yielded 17 studies.
Results: Biologic mesh was used in perineal reconstruction in 463 cases. There were 
41 perineal hernias reported but rates were not consistently reported in all studies. The 
most common complications were perineal wound infection (n =  93), perineal sinus 
and fistulae (n = 26), and perineal haematoma or seroma (n = 11). There were very few 
comparative studies, with only one randomized control trial (RCT) identified that com-
pared patients undergoing ELAPE with perineal reconstruction using a biological mesh, 
with patients undergoing a conventional abdominoperineal excision of the rectum with 
no mesh. There was no significant difference in perineal hernia rates or perineal wound 
infections between the groups. Other comparative studies comparing the use of biologic 
mesh with techniques, such as the use of myocutaneous flaps, were of low quality.
Conclusion: Biologic mesh-assisted perineal reconstruction is a promising technique 
to improve wound healing and has comparable complications rates to other techniques. 
However, there is not enough evidence to support its use in all patients who have under-
gone ELAPE. Results from high-quality prospective RCTs and national/international 
collaborative audits are required.
Keywords: eLAPe, extralevator abdominoperineal excision of rectum, extralevator abdominoperineal resection, 
pelvic floor reconstruction, biological mesh
FiGURe 1 | eLAPe technique (13). Black line indicates dissection line of 
standard APE and blue line ELAPE. Horizontal line indicates meeting point of 
abdominal and perineal dissection.
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iNTRODUCTiON
Abdominoperineal excision of the rectum (APER) is used as a 
treatment modality in patients with rectal cancer where an ante-
rior resection (AR) and an anastomosis cannot be performed (1). 
Extralevator abdominoperineal excision (ELAPE) involves the en 
bloc excision of the levator muscles and the rectum, in order to 
reduce the risk of tumor involvement in the circumferential resec-
tion margins (CRMs) and reduce the risk of tumor perforation 
intraoperatively. This method has been demonstrated as leading 
to a wider surgical margin and therefore fewer positive CRMs 
(2–5). Initially, the terminology used was “cylindrical APER” but 
with refinement and the use of MRI to highlight the area of risk 
of a positive CRM, the term ELAPE is more appropriate (4). The 
nomenclature surrounding the technique has been the source 
of much debate and confusion, with some authors noting that 
ELAPE is no different from the original description in English 
by Miles (6). Furthermore, what exactly constitutes “standard” 
surgery that allows differentiation of ELAPE has come under 
scrutiny (7).
Volumetric analysis has confirmed that ELAPE does remove 
more tissue (3), and the wider excision can, however, increase 
morbidity and wound complications and will require some 
form of perineal reconstruction (4). Perineal wound problems 
are reported in up to 57% of patients undergoing APER (8), 
although the precise rates following ELAPE are not yet known. 
Given that ELAPE produces a larger defect in the pelvic floor, 
leaving only the ischiorectal fat and skin to close the perineal 
wound; it is presumed that the perineal complication rate is 
higher. Furthermore, the changes in the proportion of patients 
having neoadjuvant (chemo)radiotherapy over the time course of 
ELAPE implementation are incompletely reported in individual 
studies and in national registries. If the wound fails to heal via pri-
mary intention, secondary wound healing can result in prolonged 
hospital stay that requires intensive wound care.
Various alternative techniques have been described to 
reconstruct the pelvic floor following ELAPE with the aim to 
reduce perineal wound complications and hernias. The optimal 
method of perineal reconstruction remains a matter of debate. 
Myocutaneous flaps, such as those derived from gluteus maximus 
(2, 4, 9), rectus abdominis, and latissimus dorsi muscles (4, 10), 
have been used but are associated with donor-site morbidity, flap 
necrosis, prolonged operative time, additional resources, and 
increased cost. Biologic mesh has recently been introduced as an 
alternative form of reconstruction in order to improve perineal 
wound healing and reduce perineal hernia rates (11). The mesh 
is usually placed as an inlay or bridge across the defect in the 
pelvic floor in close relation to the bony structures and sutured 
in 1-cm intervals to the origin of the levator muscles laterally 
(12). [Figure 1 (13)] The mechanism by which the use of a bridg-
ing prosthesis reduces perineal wound problems is not clear. It 
has been suggested that biological mesh allows native cellular 
ingrowth and promotes tissue remodeling, which in turn reduces 
perineal wound problems (14, 15). Alternatively, the biologic 
mesh may act as a physical barrier, supporting the pelvic contents 
(omentum, small bowel, and uterus) and minimizing the pressure 
on the skin and ischiorectal fat as they heal.
Alternative methods for removing the pressure of small bowel 
that prolapses into the pelvis, directly on the perineum include 
the following:
 (1) Omental pedicle flaps (16–18),
 (2) Mobilization of the cecum (9),
 (3) Retroversion of the uterus in female (19).
All of the above techniques are designed to close off the dead 
space in the pelvis, resulting from the removal of the rectum and to 
keep the small bowel out of the pelvis. Of these methods, the most 
widely established is the omental pedicle. However, these techniques 
largely related to an era of open surgery, and they have mostly been 
abandoned with the move to laparoscopic and other minimally 
invasive techniques and are not representative of contemporary 
practice. Omental pedicles are associated with perineal wound 
complication rates of 14–18% and decreased wound dehiscence 
in comparison to primary closure (16, 18) whereas others show 
no advantage to this technique (20). Mobilization of the cecum is 
uncommon and evidence is limited to case reports (9). Retroversion 
of the uterus involves retroverting the uterus and securing it to the 
bony pelvis at a level where it obliterates the pelvis, with the use of 
non-absorbable suture material (19). This can be achieved via the 
abdominal or perineal wound, although it has been associated with 
dyspareunia and positional menstruation (19).
The aim of this review is to provide an overview of the evidence 
for the use of biologic mesh in the reconstruction of the pelvic 
floor after extralevator abdominoperineal excision.
MeTHODS
A systematic search of PubMed was conducted using the search 
terms: “ELAPE,” “extralevator abdominoperineal excision of 
rectum,” or “extralevator abdominoperineal resection” in order to 
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identify studies evaluating the use of biologic mesh for reconstruc-
tion of the pelvic floor. Titles, abstracts, and full texts were analyzed 
for studies reporting on the use of biologic mesh for reconstruction 
of the pelvic floor. Inclusion criteria were studies that used biologic 
mesh for perineal reconstruction. Studies were excluded if only 
synthetic mesh was used or if there was no mention of a mesh. 
Furthermore, studies on patients under the age of 18 were excluded 
as well as non-English language studies, technical tips, confer-
ence abstracts, or duplicates series from the same research group. 
Overall, the search yielded 17 studies for analysis after the exclusion 
of review articles. The study characteristics are presented (Table 1).
ReSULTS
There were 15 case series, one randomized control trial (RCT), and 
one case report identified. A biologic mesh was used in perineal 
reconstruction in 463 cases. The different types of biologic mesh 
used were cross-linked porcine dermal collagen (Permacol™) in 
206 cases, 44 using porcine intestinal submucosa (Surgisis©), 136 
using human acellular dermal matrix, and 9 using a combination 
of Permacol™ and Surgisis©. Two studies did not specify the type 
of biologic mesh used.
Perineal Hernia
There were 41 perineal hernias reported, but rates were not con-
sistently reported in all studies. In those studies that did report 
perineal hernia rates, it was difficult to delineate whether hernias 
occurred in patients that had perineal reconstruction using a 
biological or synthetic mesh or a myocutaneous flap.
Perineal wound infection/Healing 
Problems
Perineal wound infection was reported explicitly in 93 cases, 
whereas the overall rate of perineal problems was much higher. 
Perineal sinus and fistulae were reported in 26 cases, with a 
further 11 cases of perineal hematoma or seroma. Some studies 
have described “perineal wound complications” but not specified 
whether they were related to infection, dehiscence, hernia, or 
pain (Table 1).
The most common complications were perineal wound 
infection and perineal sinus. However, there are no standardized 
measures for reporting perineal outcomes of any type following 
ELAPE. Definitions of wound infection, wound healing prob-
lems, perineal herniation, pain measurement, and functional 
status assessment are inconsistent between studies, thus limiting 
comparisons.
There are very few studies comparing the use of biologic mesh 
for perineal reconstruction for ELAPE. Two case series compared 
biologic mesh with myocutaneous flaps and one series compared 
laparoscopic ELAPE with laparoscopic and open APER. However, 
they are all of low-level evidence (level 4). Only one RCT was 
identified that compared patients undergoing ELAPE with 
perineal reconstruction using a biological mesh, with patients 
undergoing a conventional APER with no mesh. There was no 
significant difference in perineal hernia rates or perineal wound 
infections between the two groups.
DiSCUSSiON/SUMMARY
The use of ELAPE over conventional APER is becoming more 
widespread despite the reservations of some (13), and the optimal 
method of perineal wound closure remains a topic of discussion. 
The reported results of primary closure of the perineal defect are 
poor (34) and most surgeons performing ELAPE opt for an adjunct 
(35). The literature analyzed suggests that perineal closure using a 
biologic mesh produces wound infection and complication rates 
that are comparable to other methods of reconstruction, such as 
myocutaneous flaps. Myocutaneous flap reconstruction using 
a vertical rectus abdominis (VRAM), gracilis, or the gluteus 
maximus, however, has short-term disadvantages, such as longer 
operative times and the need for plastic surgical expertise, result-
ing in higher operative costs, flap necrosis, wound complications 
at the donor site, and longer bed rest (15). Longer term incisional 
hernias at the VRAM donor site and reduced abdominal wall 
strength have been reported (36). Biologic mesh reconstruction 
avoids all of these potential complications.
Synthetic non-absorbable mesh is associated with high infec-
tion rate in contaminated fields and consequently is considered 
by many to be contra-indicated for use in perineal reconstruction 
following ELAPE (37). The role of newer, absorbable synthetic 
meshes is, as yet, unclear. Biologic meshes are composed of an 
acellular collagen matrix that is believed to allow tissue regen-
eration, neovascularization, repopulation with fibroblasts, and 
therefore provides a scaffold for tissue incorporation (15, 23). This 
is thought to reduce the rate of infection. However, the overall 
volume and quality of evidence available regarding biologic mesh 
use for perineal reconstruction following ELAPE is poor, with 
observational retrospective studies predominating. There have 
been some attempts at comparative studies, but these too have 
been of low quality with a high risk of bias and confounding fac-
tors. Head-to-head randomized trials or high-quality prospective 
cohort studies comparing biological with synthetic mesh, types 
of biologic mesh, and biologic mesh with (myo)fasciocutaneous 
flaps are also lacking, partly because there is no consensus among 
surgeons as to the optimal biologic mesh or optimal tissue flap. 
Trials directly comparing any technical adjunct to primary clo-
sure alone as a control arm may be difficult to perform in light of 
the lack of equipoise among surgeons and possibly even unethical 
given the reported poor results of primary closure. Furthermore, 
there does not appear to be a consensus in the studies regarding 
perineal outcome reporting. There are a variety of different end 
points recorded across the studies, such as perineal defect size, 
blood loss, and operating time. There needs to be a focus on 
standardized definitions and reporting of perineal healing rates, 
perineal hernia, and functional outcomes following ELAPE (38).
Jensen et  al. also examined the long-term follow-up for 
patients undergoing pelvic floor reconstruction with a biologic 
mesh following ELAPE (25). As well as low perineal hernia rates, 
there was no major restriction in movement or sitting. Chronic 
pain had resolved in all patients at a median of 8 months, and 
there was no major limitation to walking. However, other studies 
evaluating quality-of-life scores using validated tools (11) dem-
onstrated a favorable comparison to the reference population of 
patients with colorectal cancer who had undergone a standard 
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TABLe 1 | Reconstruction of the pelvic floor after eLAPe.
Reference Study 
design
No. of pts Age Sex (M:F) Patient characteristics Material used intervention Follow-up 
(months)
Complications Loe
Christensen 
et al. (21)
Case series 57 FLAP: 67.8 
(32.7–86.2)
11:22 52 primary rectal cancer
5 local recurrence
48 patients (84%) 
received neoadjuvant 
CRT
Gluteal flaps: 33 ELAPE for low rectal 
cancer
Median follow-
up: gluteal flap: 
3.2 years (1.7– 4.3)
Gluteal flap vs. biologic
Perineal hernia: 7 vs. 0, P < 0.01
Infectious complications: 2 (17%) 
vs. 4 (6%), P < 0.26
1 patient per group with a 
persistent perineal sinus
4
MESH: 69.7 
(48.7–84.5)
10:14 Permacol: 24 Biologic mesh: 1.7 
(0.4 –2.2) years
Dalton et al. 
(22)
Case series 31 Mean 
66.8 ± SD 
11.4 years
8:23 Neoadjuvant CRT: 14 VRAM flap: 1
Permacol: 30
Open ELAPE Median: 20 (0–45) Breakdown of perineal wound: 6
Skin paddle necrosis of a VRAM 
flap: 1
Perineal wound hematoma: 1
Minor wound discharge: 9
4
Han et al. 
(23)
Case series 12 68 (49–80) 7:5 Ultra low rectal cancer. 
Neoadjuvant CRT: 3
HADM Cylindrical APR-open Median: 8 (2–16) Asymptomatic seroma: 1
Perineal wound infection: 1
4
Han et al. 
(14)
Open label 
RCT
67 63 median 
(44–81)
68 (32–84)
20:15
21:11
Neoadjuvant therapy: 10
Neoadjuvant therapy: 9
HADM
None
ELAPE: 35
APER: 32
Median: 29 (12–48)
Median: 22 (14–46)
Bowel perforation: 2
Perineal wound infection: 4
Perineal seroma: 4
Peristomal hernia: 16
Abdominal wound infection: 2
Perineal herniation: 5
Bowel perforation: 5
Perineal wound infection: 6
Peristomal hernia: 13
Abdominal wound infection: 3
Perineal herniation: 4
2
Han et al. 
(24)
Multicenter 
prospective 
cohort study 
(case series)
109 (102) 61 years 
(27–78)
60:42 HADM Biological mesh: 83 
(81.4%)
Primary closure: 19 
(18.6%)
44 median (18–68) Biological mesh
Perineal wound complications: 15
Infection: 5
Seroma: 5
Hernia: 4
Abdominal wound infection: 3
Primary closure
Perineal wound complications: 9
Infection: 3
Seroma: 1
Hernia: 2
Wound dehiscence: 3
Chronic sinus: 1
Abdominal wound infection: 2
4
(Continued)
Reference Study 
design
No. of pts Age Sex (M:F) Patient characteristics Material used intervention Follow-up 
(months)
Complications Loe
Jensen 
et al. (25)
Case series 53 – 31 
agreed to 
long-term f/u
69 (33–83) 
median
33:20 Neoadjuvant CRT: 23 Permacol 6 planned open
47 laparoscopic of which 
7 converted to open
Median: 36 (1–67) Perineal hernia: 3
Fistuale: 11
Perineal abscess: 4
Superficial wound infections: 4
Removal of mesh: 1
Implantation of new mesh: 1
4
Kipling et al. 
(26)
Case series 28 70 
(52–81 years) 
median
20:8 Neoadjuvant therapy
None: 9 (32%)
Short course: 2 (7%)
Long course: 17 (61%)
Permacol Lap ELAPE, 5 conversions Median 38 (23–66) Bowel perforation: 1
Persistent perineal sinus at 
6 months: 1
Delayed healing of the perineal 
wound: 1
4
Peacock 
et al. (15)
Case series 
(comparative)
15 68 median 
(48–74)
57 median 
(47–68)
4:1
9:1
Long-course CT/RT: 4
Long-course RT: 1
Long-course CT/RT: 6
Long-course RT: 2 (not 
suitable for CT): 2
VRAM: 5
Surgisis: 10
Cylindrical APER Median: 29 (23–35) 
13 (3–27)
Perineal wound infection (wound 
dehiscence): 1
Flap necrosis: 1
Wound hematoma: 1
Perineal sinus: 1
Superficial perineal wound 
infection: 2
Abscess/collection: 3
4
Peacock 
et al. (27)
Case series 34 Median 
62 years 
(40–77)
27:7 Long-course CRT: 26
Long-course RT (not 
suitable for CT): 2
Not required/declined: 6
Surgisis: Cylindrical APER Median: 21 (1–54) Perineal sinus: 5
Superficial perineal wound 
infection: 3
Abscess/collection: 3
Parastomal hernia: 1
4
Vaughan-
Shaw et al. 
(28)
Case series 
(case–control)
16
10
10
71 (49–88)
72 (52–87)
72.5 (46–89)
7:9
5:5
8:2
Short-course RT: 7
Long-course CRT: 9
Short-course RT: 7
Long-course CRT: 2
Short-course RT: 2
Long-course CRT: 5
9 Permacol/
Surgisis 
(omentoplasty: 7)
Laparoscopic ELAPE: 14 
(1 conversion)
Open: 2
Lap APER: 10
Open APER: 10
Return to theater (<30 days): 2
Perineal wound complications: 2
Perineal wound complications: 5
Perineal hernia: 2
Infection: 1
Return to theater (<30 days): 1
In-hospital mortality: 1
Perineal wound complications: 2
4
Wille-
Jørgensen 
et al. (29)
Case series 11 63 median 
(51–77)
7:4 Neoadjuvant CRT: 6 Permacol Laparoscopic APER: 9 
(2 conversions) Open 
APER: 2
Median: 12 (3–18) Mesh removal 2nd to infection: 1
Rectal perforation: 1
Long-lasting perineal pain: 6
Fistula: 1
4
Chi et al. 
(30)
Case series 6 Mean: 69 4:2 Neoadjuvant CRT 4 HADM Mean: 5 (2–19) Surgical site infection: 2 4
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TABLe 1 | Continued
(Continued)
Reference Study 
design
No. of pts Age Sex (M:F) Patient characteristics Material used intervention Follow-up 
(months)
Complications Loe
Palmer 
et al. (31)
Case series 193 66 median 
(28–87)
81:112 Neoadjuvant CRT: 91
RT alone: 92
Locally advanced tumor 
on MRI (T4)-126 (65%)
Perineal closure
Gluteal flap: 99 
(51)
Biological mesh: 
66 (34)
Closure directly: 
28 (15)
Pelvic exenteration: 25, 
extended resection with 
parts of other organs: 56 
ELAPE alone: 112
Median 31 (0–156) Intra-operative perforation: 19
30-day postoperative mortality: 6
4
West et al. 
(4)
Retrospective 
case series 
(multicenter)
176
124
66 (58–73) 
Median
68 (57–75) 
median
116:54
6-unknown
87:37
Neoadjuvant RT
Yes: 135
No: 35
Unknown: 11
Neoadjuvant CT
Given: 84
Not given: 81
Unknown: 11
Neoadjuvant RT
Yes: 90
No: 24
Unknown: 10
Neoadjuvant CT
Given: 48
Not given: 66
Unknown: 10
Gluteus maximus: 
60
Rectus abdominis: 
12
Latissimus dorsi: 1
Permacol: 11
ELAPE: 176
Open surgery: 122
Laparoscopic surgery: 19
Unknown: 35
APER: 124
Open surgery: 56
Laparoscopic surgery: 4
Unknown: 64
NS
NS
Wound complications
Yes: 57
Infection/breakdown/sinus: 41
Perineal hernia: 5
Other: 11
Wound complications
Yes: 11
Infection/breakdown/sinus: 7
Perineal hernia: 1
Other: 3
Unknown: 26
4
Harries 
et al. (32)
Prospective 
case series
48 Median: 63 
(40–86)
36:12 Neoadjuvant  
treatment: 43
Permacol ELAPE
Lap: 28
Conversion: 7
Open: 23
Median: 27 (1–85) Specimen perforation: 3 (6.4%)
Unhealed at 6 months: 4 (8.3%)
Perineal sinus: 7
Abdominal wound dehiscence: 1
Ureteric injury: 1
Radiological drainage of pelvic 
collections: 2
Perineal wound infections: 9
4
Kavanagh 
et al. (33)
Case report 1 72 0:1 Long-course CRT Permacol Lap ELAPE 12 NS 4
Sayers et al. 
(34)
Case series 54 Median: 69.5 
(31–90)
40:14 Neoadjuvant CRT: 52 Primary closure: 
46
Bio: 2
FLAP: 6 (VRAM: 5 
Gracilis: 1)
Lap ELAPE: 20
Open: 34
Median: 38 (9–61) Perineal complications: 24
Perineal hernia: 14
Perineal hematoma: 1
Infected myocutaneous flap: 1
Total dehiscence of the  
perineum: 1
4
APER, abdominoperineal excision of the rectum; CRT, chemoradiotherapy; CT, chemotherapy; ELAPE, extralevator abdominoperineal excision; HADM, human acellular dermal matrix; LoE, level of evidence; RCT, randomized controlled 
trial; RT, radiotherapy; VRAM, vertical rectus abdominis muscle.
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APE, whereas patients who had undergone flap reconstruction 
had a lower quality of life score (11).
Of note, a number of studies from Beijing have been included 
for analysis. The three studies include patients managed over an 
approximately 3-year period, and there is overlap of the studies 
within the time period, therefore suggesting some replication. One 
study is classified as a case series (23), the second a RCT (14), and the 
third another case series (24). It is unclear as to whether these three 
studies are from the same patient group or three different cohorts.
CONCLUSiON
Overall, the use of a biologic mesh to close perineal defects 
has comparable complications rates to myocutaenous flaps but 
may offer advantages, such as shorter operating time and early 
mobilization, which results in a more cost-effective repair (15). 
Biologic mesh-assisted perineal reconstruction is a promising 
technique to improve wound healing, but there is not enough 
evidence to support its use in all patients who have undergone 
ELAPE. The results from high-quality prospective RCTs or 
national/international collaborative audits using statistical 
process control as a methodology of assessment of improvement 
are required.
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